184
-3.16%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Bundamedik Tbk PT
Its shares trade on IDX under the ticker BMHS.JK. It has been listed since 6 July 2021. In the fiscal year to 31 December 2025, it reported revenue of IDR 1.61trn and net income of IDR 12.42bn. At that date it held total assets of IDR 4.02trn and shareholders' equity of IDR 1.95trn.
PT Bundamedik Tbk is a holding company, with engages in the provision of healthcare and medical technology services. The company is headquartered in Jakarta Pusat, Dki Jakarta. The company went IPO on 2021-07-06. The Company’s segments include Healthcare services and Others. The firm is a health care service provider that has medical technology at Bunda Jakarta Woman and Children Hospital, Bunda Jakarta General Hospital , Bunda Margonda General Hospital , Bunda Padang General Hospital, Bunda Ciputat Woman and Children Hospital, Bunda Citra Harapan General Hospital, AZ Zahra Woman and Children Hospital, BIC Pacific Place & BIC Vida Bekasi, Morula IVF (In Vitro Fertilization) Indonesia, Diagnos (Laboratory), Bunda Global Pharma, Emergency Response (ER), Bunda Diklat Indonesia, IRSI (Indonesian Reproductive Sciences Institute), Prima Dental, Indonesia Medical Tourism Board (IMTB) and Daima Norwood Menteng. Its subsidiaries include T Citra Ananda, PT Bunda Medika Wisesa, PT Visiscan Indonesia, PT Bunda Medika Dewata, and PT Sasana Mitra Bunda.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 6 Jul 2021
- Employees
- 1,285
- Website
- bmhs.co.id/id ↗
Leadership
Pay as last reported
- Mr. Ivan SiniPresident Commissioner
- Mr. Mesha SiniPresident Director
- Mr. Wishnutama KusubandioIndependent Deputy President Commissioner
- Mr. Tedy HomoginDirector
- Mr. Taufik SantosoDirector
- Mr. Nurhadi YudiyanthoDirector
- Ms. Josephine TobingCorporate Secretary
- Mr. Rito Alam SiniCommissioner
- Mr. Chairul NasutionIndependent Commissioner
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Bunda Jakarta Woman and Children Hospital provides specialized healthcare services.
- Bunda Margonda General Hospital serves a large urban population in Indonesia.
- Bunda Ciputat Woman and Children Hospital focuses on women and children health care.
Weaknesses
- Bunda Padang General Hospital is located in a less populated area of Indonesia.
- Bunda Citra Harapan General Hospital faces competition in the Jakarta metropolitan area.
- Bunda Diklat Indonesia lacks international accreditation for training programs.
Opportunities
- Bunda Global Pharma can expand into the growing pharmaceutical market in Indonesia.
- Bunda Jakarta General Hospital can leverage medical tourism opportunities in Indonesia.
- Bunda Medical Tourism Board (IMTB) can attract more international patients.
Threats
- Bunda Padang General Hospital is vulnerable to regional economic downturns.
- Bunda Citra Harapan General Hospital faces regulatory changes in healthcare services.
- Bunda Diklat Indonesia must adapt to evolving medical training standards.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.